NCT01533766

A Safety, Efficacy Study of CombiflexOmega Versus SmofKabiven in Patients With Parenteral Nutrition

A Randomized, Open, Multicenter, Compared Phase III Trial to Evaluate the Safety, Efficacy of CombiflexOmega and SmofKabiven in Postoperative Patients Requiring Parenteral Nutrition

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: JW Life Science · Industry
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the safety and efficacy of CombiflexOmega in comparison to SmofKabiven in postoperative patients requiring parenteral nutrition.

Conditions

• Parent

Interventions

Type	Name	Description
DRUG	CombiflexOmega	intravenously over 5 days infusion
DRUG	SmofKabiven	intravenously over 5 days infusion

Timeline

• Start date: 2011-08-01
• Primary completion: 2012-01-01
• Completion: 2012-02-01
• First posted: 2012-02-15
• Last updated: 2013-02-18

Locations

1 site across 1 country: South Korea